Cite Filings / AVTX / 0001079973-18-000575
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Avalo Therapeutics, Inc. · Filed 2018-10-18 · Acc 0001079973-18-000575

Documents 1

  • SC 13D/A Beneficial Ownership Report , fremantle_13.htm

Around this filing

  • 2018-10-18 4 Changes in Ownership
  • 2018-10-18 3 Initial Statement of Ownership
  • 2018-10-18 4 Changes in Ownership
  • 2018-10-18 4 Changes in Ownership
  • 2018-10-18 SC 13D/A Beneficial Ownership Report
  • 2018-10-18 SC 13D/A Beneficial Ownership Report
  • 2018-09-27 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · BVF PARTNERS L P/IL 1.7%
  2. 2026-11-16 SCHEDULE 13G/A · Point72 Asset Management, L.P. 3.0%
  3. 2026-11-13 SCHEDULE 13G · Farallon Capital Management, L.L.C. 7.4%
  4. 2026-05-15 SCHEDULE 13G/A · Logos Global Management LP 3.2%
  5. 2026-04-01 SCHEDULE 13G · Logos Global Management LP 5.6%
Loading fremantle_13.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…